SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Alpine Immune Sciences, Inc. (ALPN) .
本页证实的标准:
- VALUE (20/100, 未通过) — 分析师共识目标价暗示当前价格存在下行风险 ($55.00, 15.3%).
- 分析师共识目标价 $55.00 (-15.3% 下行风险) — 分析师认为当前价格水平存在明显下行风险。
SharesGrow 综合评分： 31/100 其中 0/7 项标准通过。
SharesGrow 7-Criteria Score
✗
价值
20/100
Price-to-Earnings & upside
Proven by this page
~
健康
67/100
Debt-to-Equity & liquidity
→ Health
估值概览 — ALPN
估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率55.18
EV/EBITDA0.0
每股数据
EPS (TTM)$-0.64
每股账面价值$0.00
每股营收$1.18
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
分析师目标价$55.00 (-15.3%)
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2014 |
$-6.59 |
$0.00 |
$-15.04M |
- |
| 2015 |
$-9.74 |
$492K |
$-22.82M |
-4637.8% |
| 2016 |
$-8.12 |
$2.95M |
$-31.46M |
-1066.5% |
| 2017 |
$-1.20 |
$1.73M |
$-7.78M |
-449.6% |
| 2018 |
$-2.63 |
$705K |
$-36.49M |
-5175.5% |
| 2019 |
$-2.32 |
$1.74M |
$-42.53M |
-2444.5% |
| 2020 |
$-1.34 |
$9.34M |
$-27.94M |
-299.3% |
| 2021 |
$-1.98 |
$23.44M |
$-50.33M |
-214.7% |
| 2022 |
$-1.73 |
$30.06M |
$-57.76M |
-192.1% |
| 2023 |
$-0.64 |
$58.88M |
$-32.18M |
-54.7% |
